An Issue of Quality
December 17, 2015
2015 has been a difficult year for Indian pharma companies – and ASSOCHAM is calling for the country to get its “house in order”.
1 min read
December 17, 2015
2015 has been a difficult year for Indian pharma companies – and ASSOCHAM is calling for the country to get its “house in order”.
1 min read
December 17, 2015
A new personalized test aims to predict side effects
1 min read
December 17, 2015
The AMA calls for a ban on direct-to-consumer drug advertising in the US. But is such prohibition realistic?
1 min read
December 17, 2015
The UK aims high with a new manufacturing center designed to meet the needs of cell and gene therapies
1 min read
December 17, 2015
Pfizer and Allergan are to combine to form the world’s biggest pharma behemoth – but much attention has focused on the tax implications
1 min read
December 17, 2015
From Iceland’s volcanic springs to a lab in South Denmark; does the microbe Sulfolobus. islandicus hold the key to a drug’s safe transit through the gut?
1 min read
December 17, 2015
A capsule being developed in Ireland aims to contain not medicine, but process analytical technology
1 min read
December 17, 2015
Digesting regulatory guidance is not always easy, but understanding the main points – and then paying attention to the details – will improve your chances of success. Here, I break down the latest analytical guidance into seven bite size chunks to lend a h
1 min read
December 17, 2015
The Ebola epidemic spurred a tremendous amount of R&D in search of vaccines and treatments – and yet it was a relatively low impact global emergency compared with malaria. How can we incentivize development in other important health areas?
1 min read
December 17, 2015
The reverse merger between Pfizer and Allergan is the most recent chapter in a decades-long transformation of the pharma industry, but I believe it also represents a rapid acceleration of a troubling trend.
1 min read
False
False